Hangzhou AGS MedTech Co., Ltd. (SHA:688581)

Market Cap	4.87B
Revenue (ttm)	653.67M
Net Income (ttm)	296.86M
Shares Out	80.58M
EPS (ttm)	3.68
PE Ratio	16.41
Forward PE	14.45
Dividend	1.38 (2.28%)
Ex-Dividend Date	Jun 21, 2024

Volume	348,609
Average Volume	675,588
Open	60.50
Previous Close	60.45
Day's Range	60.03 - 60.72
52-Week Range	46.83 - 74.88
Beta	0.39
RSI	44.77
Earnings Date	Apr 23, 2025

About Hangzhou AGS MedTech

Hangzhou AGS MedTech Co., Ltd. engages in the research, development, production, sale, and service of endoscopic surgery equipment and accessories in China. It offers hemoclips; bipolar generators, CR4500 CO2 regulation units, and UW600-II water pumps; disposable stone extraction baskets, nasal biliary drainage catheters, sphincterotomes, disposable guide wires, and stone retrieval balloons; disposable bipolar ESD knives, polypectomy snares, and disposable sclerotherapy needles; and disposable grasping forceps and disposable biopsy forceps. The...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 744
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688581

Financial Performance

In 2024, Hangzhou AGS MedTech's revenue was 636.63 million, an increase of 25.14% compared to the previous year's 508.75 million. Earnings were 293.39 million, an increase of 35.06%.